McKESSON CORPORATION (MCK) FY2025 Annual P&L / Income Statement

McKESSON CORPORATION (MCK) FY2025 Annual P&L / Income Statement

Income statement for 2024-04-01 through 2025-03-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Revenues

359,051,000,000 US dollars

Cost of sales

345,728,000,000 US dollars

Gross profit

13,323,000,000 US dollars

Total operating expenses

8,901,000,000 US dollars

Operating income

4,422,000,000 US dollars

Other income (expense), net (calculated)

negative 63,000,000 US dollars

Income from continuing operations before income taxes

4,359,000,000 US dollars

Income tax expense

878,000,000 US dollars

Net income

3,481,000,000 US dollars

U.S. Pharmaceutical

327,717,000,000 US dollars

Prescription Technology Solutions

5,216,000,000 US dollars

Medical-Surgical Solutions

11,386,000,000 US dollars

International

14,721,000,000 US dollars

Claims and litigation charges, net

108,000,000 US dollars

Selling, distribution, general, and administrative expenses

8,507,000,000 US dollars

Restructuring, impairment, and related charges, net

286,000,000 US dollars

Revenue before reconciliation (calculated)

359,040,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.

Corporate

11,000,000 US dollars. Reported reconciliation to consolidated revenue.

Loss from discontinued operations, net of tax

0 US dollars. Reported below-tax contribution to net income.

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.
• Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
• Of which attributable to McKESSON CORPORATION: $3.30 B; to noncontrolling interests: $186.00 M.